Zimmer Biomet Announces Fourth Quarter and Full-Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Zimmer Biomet (ZBH) PT Lowered to $101 at Credit Suisse
February 4, 2019 8:41 AM ESTCredit Suisse analyst Matt Miksic lowered the price target on Zimmer Biomet (NYSE: ZBH) to $101.00 (from $102.00) while maintaining a Underperform rating.
... MoreZimmer Biomet (ZBH) PT Raised to $150 at Jefferies; Train is Finally Leaving the Station
February 1, 2019 1:14 PM ESTJefferies analyst Raj Denhoy raised the price target on Zimmer Biomet (NYSE: ZBH) to $150.00 (from $140.00) while maintaining a Buy rating following strong Q4.
Denhoy said 'The Train is Leaving the Station (Finally)"
... MoreUPDATE: Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 1c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus
February 1, 2019 6:12 AM EST(Updated - February 1, 2019 6:13 AM EST)
Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.18, versus $2.17 reported last year. Revenue for the quarter came in at $2.07 billion versus the consensus estimate of $2.06 billion.
"We are encouraged with the solid close to 2018,... More
